Cardiff University | Prifysgol Caerdydd ORCA
Online Research @ Cardiff 
WelshClear Cookie - decide language by browser settings

My health: whose responsibility? Low-dose aspirin and older people

Elwood, Peter Creighton, Longley, Marcus and Morgan, Gareth 2006. My health: whose responsibility? Low-dose aspirin and older people. Expert Review of Cardiovascular Therapy 4 (5) , pp. 755-764. 10.1586/14779072.4.5.755

Full text not available from this repository.

Abstract

The benefit of aspirin as a prophylactic after a thrombotic event was first observed 30 years ago. Its use after coronary or cerebral thrombosis, and in patients judged to be at increased risk of a thrombotic event, is now virtually mandatory, unless there are signs of intolerance. The present policy in the UK for cardiovascular protection by low-dose aspirin is dependent upon the identification of people at high vascular risk. The policy has had only very limited success, partly owing to the fact that only a relatively small proportion of people with levels of vascular risk factors that would justify aspirin prophylaxis are identified. In fact, it has been demonstrated that the application of accepted guidelines for aspirin prophylaxis to risk factor data in representative UK population samples gives a cost-effective evidence-base for a reasonable extension of prophylaxis to all people aged over approximately 50 years. It is possible that reductions in both dementia and cancer incidence could also follow the wider use of low-dose aspirin but further research on these outcomes is urgently required. The evidence on possible benefits and harm from low-dose aspirin should therefore be publicized widely, and everything possible should be done to stimulate discussion involving the general public. In the end, however, the preservation of health is one’s own responsibility and, therefore, people should generally be encouraged to evaluate the evidence on health-promotion measures, including low-dose aspirin, and take responsibility for their own health.

Item Type: Article
Date Type: Publication
Status: Published
Schools: Medicine
Uncontrolled Keywords: aspirin; health promotion; older subjects; prophylaxis; vascular risk
Publisher: Future Drugs
ISSN: 1477-9072
Last Modified: 04 Jun 2017 06:46
URI: http://orca-mwe.cf.ac.uk/id/eprint/64547

Citation Data

Cited 5 times in Google Scholar. View in Google Scholar

Cited 2 times in Scopus. View in Scopus. Powered By Scopus® Data

Actions (repository staff only)

Edit Item Edit Item